TY - JOUR AU - Donnelly, J. J. AU - Ulmer, J. B. AU - Liu, M. A. PY - 1997 DA - 1997// TI - DNA vaccines JO - Life sciences VL - 60 UR - https://doi.org/10.1016/S0024-3205(96)00502-4 DO - 10.1016/S0024-3205(96)00502-4 ID - Donnelly1997 ER - TY - JOUR AU - Gurunathan, S. AU - Klinman, D. M. AU - Seder, R. A. PY - 2000 DA - 2000// TI - DNA vaccines: immunology, application, and optimization JO - Annual review of immunology VL - 18 UR - https://doi.org/10.1146/annurev.immunol.18.1.927 DO - 10.1146/annurev.immunol.18.1.927 ID - Gurunathan2000 ER - TY - JOUR AU - Hung, C. F. AU - Wu, T. C. PY - 2003 DA - 2003// TI - Improving DNA vaccine potency via modification of professional antigen presenting cells JO - Current opinion in molecular therapeutics VL - 5 ID - Hung2003 ER - TY - JOUR AU - Tsen, S. W. AU - Paik, A. H. AU - Hung, C. F. AU - Wu, T. C. PY - 2007 DA - 2007// TI - Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells JO - Expert review of vaccines VL - 6 UR - https://doi.org/10.1586/14760584.6.2.227 DO - 10.1586/14760584.6.2.227 ID - Tsen2007 ER - TY - JOUR AU - Gelebart, P. AU - Opas, M. AU - Michalak, M. PY - 2005 DA - 2005// TI - Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum JO - The international journal of biochemistry & cell biology VL - 37 UR - https://doi.org/10.1016/j.biocel.2004.02.030 DO - 10.1016/j.biocel.2004.02.030 ID - Gelebart2005 ER - TY - JOUR AU - Cheng, W. F. AU - Hung, C. F. AU - Chai, C. Y. AU - Hsu, K. F. AU - He, L. AU - Ling, M. AU - Wu, T. C. PY - 2001 DA - 2001// TI - Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen JO - The Journal of clinical investigation VL - 108 UR - https://doi.org/10.1172/JCI200112346 DO - 10.1172/JCI200112346 ID - Cheng2001 ER - TY - JOUR AU - Kim, J. W. AU - Hung, C. F. AU - Juang, J. AU - He, L. AU - Kim, T. W. AU - Armstrong, D. K. AU - Pai, S. I. AU - Chen, P. J. AU - Lin, C. T. AU - Boyd, D. A. AU - Wu, T. C. PY - 2004 DA - 2004// TI - Comparison of HPV DNA vaccines employing intracellular targeting strategies JO - Gene Ther VL - 11 UR - https://doi.org/10.1038/sj.gt.3302252 DO - 10.1038/sj.gt.3302252 ID - Kim2004 ER - TY - JOUR AU - Peng, S. AU - Ji, H. AU - Trimble, C. AU - He, L. AU - Tsai, Y. C. AU - Yeatermeyer, J. AU - Boyd, D. A. AU - Hung, C. F. AU - Wu, T. C. PY - 2004 DA - 2004// TI - Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6 JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.16.8468-8476.2004 DO - 10.1128/JVI.78.16.8468-8476.2004 ID - Peng2004 ER - TY - JOUR AU - Kim, T. W. AU - Lee, J. H. AU - Hung, C. F. AU - Peng, S. AU - Roden, R. AU - Wang, M. C. AU - Viscidi, R. AU - Tsai, Y. C. AU - He, L. AU - Chen, P. J. AU - Boyd, D. A. AU - Wu, T. C. PY - 2004 DA - 2004// TI - Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.9.4638-4645.2004 DO - 10.1128/JVI.78.9.4638-4645.2004 ID - Kim2004 ER - TY - JOUR AU - Cai, S. X. PY - 2007 DA - 2007// TI - Small molecule vascular disrupting agents: potential new drugs for cancer treatment JO - Recent Pat Anticancer Drug Discov VL - 2 UR - https://doi.org/10.2174/157489207779561462 DO - 10.2174/157489207779561462 ID - Cai2007 ER - TY - JOUR AU - Baguley, B. C. PY - 2003 DA - 2003// TI - Antivascular therapy of cancer: DMXAA JO - The lancet oncology VL - 4 UR - https://doi.org/10.1016/S1470-2045(03)01018-0 DO - 10.1016/S1470-2045(03)01018-0 ID - Baguley2003 ER - TY - JOUR AU - McKeage, M. J. AU - Fong, P. AU - Jeffery, M. AU - Baguley, B. C. AU - Kestell, P. AU - Ravic, M. AU - Jameson, M. B. PY - 2006 DA - 2006// TI - 5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1939 DO - 10.1158/1078-0432.CCR-05-1939 ID - McKeage2006 ER - TY - JOUR AU - Lin, K. Y. AU - Guarnieri, F. G. AU - Staveley-O'Carroll, K. F. AU - Levitsky, H. I. AU - August, J. T. AU - Pardoll, D. M. AU - Wu, T. C. PY - 1996 DA - 1996// TI - Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen JO - Cancer research VL - 56 ID - Lin1996 ER - TY - JOUR AU - Hung, C. F. AU - Tsai, Y. C. AU - He, L. AU - Wu, T. C. PY - 2007 DA - 2007// TI - DNA Vaccines Encoding Ii-PADRE Generates Potent PADRE-specific CD4(+) T-Cell Immune Responses and Enhances Vaccine Potency JO - Mol Ther VL - 15 ID - Hung2007 ER - TY - JOUR AU - Wu, T. C. AU - Guarnieri, F. G. AU - Staveley-O'Carroll, K. F. AU - Viscidi, R. P. AU - Levitsky, H. I. AU - Hedrick, L. AU - Cho, K. R. AU - August, J. T. AU - Pardoll, D. M. PY - 1995 DA - 1995// TI - Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens JO - Proc Natl Acad Sci USA VL - 92 UR - https://doi.org/10.1073/pnas.92.25.11671 DO - 10.1073/pnas.92.25.11671 ID - Wu1995 ER - TY - JOUR AU - Moilanen, E. AU - Thomsen, L. L. AU - Miles, D. W. AU - Happerfield, D. W. AU - Knowles, R. G. AU - Moncada, S. PY - 1998 DA - 1998// TI - Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid JO - British journal of cancer VL - 77 UR - https://doi.org/10.1038/bjc.1998.68 DO - 10.1038/bjc.1998.68 ID - Moilanen1998 ER - TY - JOUR AU - Peggs, K. S. AU - Quezada, S. A. AU - Allison, J. P. PY - 2009 DA - 2009// TI - Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists JO - Clinical and experimental immunology VL - 157 UR - https://doi.org/10.1111/j.1365-2249.2009.03912.x DO - 10.1111/j.1365-2249.2009.03912.x ID - Peggs2009 ER - TY - JOUR AU - Xu, W. AU - Liu, L. Z. AU - Loizidou, M. AU - Ahmed, M. AU - Charles, I. G. PY - 2002 DA - 2002// TI - The role of nitric oxide in cancer JO - Cell research VL - 12 UR - https://doi.org/10.1038/sj.cr.7290133 DO - 10.1038/sj.cr.7290133 ID - Xu2002 ER - TY - JOUR AU - van der Veen, R. C. PY - 2001 DA - 2001// TI - Nitric oxide and T helper cell immunity JO - International immunopharmacology VL - 1 UR - https://doi.org/10.1016/S1567-5769(01)00093-5 DO - 10.1016/S1567-5769(01)00093-5 ID - van der Veen2001 ER - TY - CHAP AU - Zeng, Q. AU - Monie, A. AU - Peng, S. AU - Hung, C. -. F. AU - Wu, T. -. C. PY - 2010 DA - 2010// BT - Control of Cervicovaginal HPV-16 E7-Expressing Tumors by the Combination of Therapeutic HPV Vaccination and Vascular Disrupting Agents Human gene therapy (in press) ID - Zeng2010 ER - TY - JOUR AU - Bettini, M. AU - Vignali, D. A. PY - 2009 DA - 2009// TI - Regulatory T cells and inhibitory cytokines in autoimmunity JO - Current opinion in immunology VL - 21 UR - https://doi.org/10.1016/j.coi.2009.09.011 DO - 10.1016/j.coi.2009.09.011 ID - Bettini2009 ER -